Julia Huber
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- Molecular Biology Techniques and Applications 2
- Oncology 12
- Cancer Cells and Metastasis 8
- HER2/EGFR in Cancer Research 2
- Co-authors
- Alexander R. Rosenkranz (7 shared papers)Kathrin Eller (9 shared papers)Gert Mayer (5 shared papers)H. Zwierzina (8 shared papers)Arno Amann (9 shared papers)Gabriele Gamerith (9 shared papers)Jens M. Kelm (6 shared papers)Wolfgang Hilbe (5 shared papers)
- Journals
- PLoS ONE (3 papers)Cells (2 papers)American Journal of Physiology-Renal Physiology (2 papers)Blood Advances (1 paper)Neurology (1 paper)
- Partner nations
- AustriaSwitzerlandGermany
In The Last Decade
Julia Huber
31 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Oncology 321
- Immunology 213
- Cancer Research 129
- Nephrology 42
- Molecular Biology 354
Countries citing papers authored by Julia Huber
This map shows the geographic impact of Julia Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Huber more than expected).
Fields of papers citing papers by Julia Huber
This network shows the impact of papers produced by Julia Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Huber. The network helps show where Julia Huber may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 150 | |
| 2 | HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. | 1989 | 131 |
| 3 | 2014 | 130 | |
| 4 | 2019 | 121 | |
| 5 | 1995 | 109 | |
| 6 | 2017 | 55 | |
| 7 | 2010 | 43 | |
| 8 | 2013 | 41 | |
| 9 | 2006 | 35 | |
| 10 | 2016 | 33 | |
| 11 | 2009 | 26 | |
| 12 | 2016 | 23 | |
| 13 | 2008 | 19 | |
| 14 | The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis. | 2011 | 19 |
| 15 | 2017 | 19 | |
| 16 | 2007 | 18 | |
| 17 | 2010 | 18 | |
| 18 | 2021 | 12 | |
| 19 | 2023 | 11 | |
| 20 | 2016 | 11 |
About Julia Huber
Julia Huber is a scholar working on Molecular Biology, Oncology, Surgery, Immunology and Biomedical Engineering, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), 3D Printing in Biomedical Research (4 papers), Cholesterol and Lipid Metabolism (3 papers), HER2/EGFR in Cancer Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Genomics and Diagnostics (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Oncology (321 citations), Immunology (213 citations), Cancer Research (129 citations), Nephrology (42 citations) and Molecular Biology (354 citations). Julia Huber has collaborated with scholars based in Austria, Switzerland and Germany. Frequent co-authors include Alexander R. Rosenkranz, Kathrin Eller, Gert Mayer, H. Zwierzina, Arno Amann, Gabriele Gamerith, Jens M. Kelm, Wolfgang Hilbe, Anna Wolf and Myrna R. Rosenfeld. Their work appears in journals such as PLoS ONE, Cells, American Journal of Physiology-Renal Physiology, Blood Advances and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.